Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Non-Current Assets (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Non-Current Assets for 3 consecutive years, with $23.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 62.15% to $23.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $88.3 million through Dec 2025, up 162.26% year-over-year, with the annual reading at $23.3 million for FY2025, 62.15% up from the prior year.
  • Non-Current Assets for Q4 2025 was $23.3 million at Nuvation Bio, down from $24.0 million in the prior quarter.
  • The five-year high for Non-Current Assets was $24.0 million in Q3 2025, with the low at $4.2 million in Q2 2023.
  • Average Non-Current Assets over 3 years is $11.8 million, with a median of $7.1 million recorded in 2024.
  • The sharpest move saw Non-Current Assets increased 12.79% in 2024, then surged 264.44% in 2025.
  • Over 3 years, Non-Current Assets stood at $5.0 million in 2023, then surged by 184.57% to $14.4 million in 2024, then soared by 62.15% to $23.3 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $23.3 million, $24.0 million, and $24.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.